866-997-4948(US-Canada Toll Free)

XERIS Pharmaceuticals, Inc. - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 21 Pages


XERIS Pharmaceuticals, Inc. (XERIS) is a privately held development stage biopharmaceutical company. It is in the development of injectables for the treatment of endocrine and metabolic diseases. The company\'s proprietary delivery system offers needle free delivery platform. Xeris\' formulation-injection technologies enable the delivery of highly concentrated, semi-solid formulations of all drug classes, including peptides, proteins, antibodies and nucleotide-based therapeutics. The company offers Glucagon Rescue Pen (GRP) is a auto-injector. It also plans to offer its GRP in pediatric and adult dose formats. XERIS is looking forward to establish partnerships with pharmaceutical and medical device companies for the development of its products. XERIS is headquartered in Austin, Texas, the US.

This report is a source for data, analysis and actionable intelligence on the XERIS Pharmaceuticals, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 3

Key Facts 4
XERIS Pharmaceuticals, Inc. - Major Products and Services 5
XERIS Pharmaceuticals, Inc. Pipeline Products by Equipment Type 6
XERIS Pharmaceuticals, Inc. Pipeline Products by Development Stage 8
XERIS Pharmaceuticals, Inc. Pipeline Products by Therapy Area 10
Bi-Hormonal Artificial Pancreas 12
Bi-Hormonal Artificial Pancreas Product Status 12
Bi-Hormonal Artificial Pancreas Product Description 12
Product Institution Details 12
G-Pen 13
G-Pen Product Status 13
G-Pen Product Description 13
Product Institution Details 13
G-Pen Mini 14
G-Pen Mini Product Status 14
G-Pen Mini Product Description 14
Product Institution Details 14
XERIS Pharmaceuticals, Inc. - Key Competitors 15
XERIS Pharmaceuticals, Inc. - Key Employees 16
XERIS Pharmaceuticals, Inc. - Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
XERIS Pharmaceuticals, Inc., Recent Developments 18
Jul 31, 2012: Xeris Pharma Receives $336,793 Phase I/II NIH SBIR Fast Track Grant To Advance Stable, Non-Aqueous Glucagon Formulation For Bi-Hormonal Artificial Pancreas 18
Mar 20, 2012: Xeris Receives US Patent For Injection Of Ultra-Concentrated Drugs And Biologics 18
Dec 12, 2011: Xeris Pharma To Develop University of Colorado Diabetes Management Drug 19
Feb 01, 2011: Xeris Pharma Appoints Steven Prestrelski As Chief Scientific Officer 19

Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Table

 
XERIS Pharmaceuticals, Inc., Key Facts 1
XERIS Pharmaceuticals, Inc. Key Pipeline Products by Equipment Type 1
XERIS Pharmaceuticals, Inc. Key Pipeline Products by Therapy Area 1
XERIS Pharmaceuticals, Inc. Key Pipeline Products by Development Stage 1
XERIS Pharmaceuticals, Inc., Key Facts 4
XERIS Pharmaceuticals, Inc., Major Products and Services 5
XERIS Pharmaceuticals, Inc. Number of Pipeline Products by Equipment Type 6
XERIS Pharmaceuticals, Inc. Pipeline Products by Equipment Type 7
XERIS Pharmaceuticals, Inc. Number of Pipeline Products by Development Stage 8
XERIS Pharmaceuticals, Inc. Pipeline Products by Development Stage 9
XERIS Pharmaceuticals, Inc. Number of Pipeline Products by Therapy Area 10
XERIS Pharmaceuticals, Inc. Pipeline Products by Therapy Area 11
Bi-Hormonal Artificial Pancreas - Product Status 12
Bi-Hormonal Artificial Pancreas - Product Description 12
G-Pen - Product Status 13
G-Pen - Product Description 13
G-Pen Mini - Product Status 14
G-Pen Mini - Product Description 14
XERIS Pharmaceuticals, Inc., Key Employees 16

List of Chart


XERIS Pharmaceuticals, Inc. Key Pipeline Products by Equipment Type 1
XERIS Pharmaceuticals, Inc. Pipeline Products by Equipment Type 6
XERIS Pharmaceuticals, Inc. Pipeline Products by Development Stage 8
XERIS Pharmaceuticals, Inc. Pipeline Products by Therapy Area 10

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *